Clinical Supply Management Articles
-
Last-Mile Lessons For Depot-To-Site Delivery
9/7/2026
Depot-to-site delivery is more than a courier handoff. See how reconciliation gaps, temperature risks, and mismatched SLAs can turn last-mile issues into trial delays.
-
Expanded Expertise, Deeper Insight: Clinical Supply Leader Welcomes Two New Advisors
9/4/2026
Clinical Supply Leader expands its Editorial Advisory Board expertise with the addition of Éamonn McArdle (Allergy Therapeutics) and Juan Hernandez (Bensen Solutions).
-
The Hidden Cost Of The "Cheap" Comparator Drug: Why The Lowest Price Can Become The Most Expensive Choice In Clinical Trials
9/4/2026
The cheapest comparator can become the costliest choice. See how shelf life, logistics, quality, wastage and supply continuity can turn apparent savings into trial risk.
-
Could Smarter Use of Clinical Supply Data Help Avoid Certain Protocol Amendments?
9/3/2026
Clinical supply data reveals where protocol assumptions break down. Could those lessons help improve protocol design and reduce avoidable amendments?
-
AI Is Only As Good As The Data Behind Your Clinical Trial Supply Chain
9/2/2026
AI cannot fix bad clinical supply data. Disconnected systems, conflicting inventory and manual workarounds can turn smart forecasting into costly mistakes.
-
Five Places Where AI Stalls In Clinical Supply
9/1/2026
AI may be ready for clinical supply, but the systems behind it are not. Five barriers show why better models alone will not fix forecasting or waste.
-
More Than Half The Drug We Make Never Reaches A Patient
8/31/2026
More than half the drug made for clinical trials may never reach a patient. Here’s where supply planning goes wrong, and where AI can actually help.
-
Lessons In Forecasting Discipline From A $40B Supply Chain
8/31/2026
Forecasting errors rarely start with the algorithm. They start when protocol changes, enrollment and site data reach the supply plan too late to prevent waste and disruption.
-
Clinical Supply When There's No Drug To Ship
8/28/2026
When a clinical trial has no drug to ship, what becomes supply? Non-pharmacological trials still require sourcing, tracking, qualification, and control.
-
Why Clinical Supply Problems Rarely Start In Clinical Supply
8/27/2026
Clinical supply failures often start long before a stockout, when CMC, quality, regulatory, and clinical decisions create risks that supply teams inherit too late.